Literature DB >> 16709899

Hypoxia inducible factor 1 mediates hypoxia-induced TRPC expression and elevated intracellular Ca2+ in pulmonary arterial smooth muscle cells.

Jian Wang1, Letitia Weigand, Wenju Lu, J T Sylvester, Gregg L Semenza, Larissa A Shimoda.   

Abstract

Chronic hypoxia (CH) causes pulmonary vasoconstriction because of increased pulmonary arterial smooth muscle cell (PASMC) contraction and proliferation. We previously demonstrated that intracellular Ca(2+) concentration ([Ca(2+)](i)) was elevated in PASMCs from chronically hypoxic rats because of Ca(2+) influx through pathways other than L-type Ca(2+) channels and that development of hypoxic pulmonary hypertension required full expression of the transcription factor hypoxia inducible factor 1 (HIF-1). In this study, we examined the effect of CH on the activity and expression of store-operated Ca(2+) channels (SOCCs) and the regulation of these channels by HIF-1. Capacitative Ca(2+) entry (CCE) was enhanced in PASMCs from intrapulmonary arteries of rats exposed to CH (10% O(2); 21 days), and exposure to Ca(2+)-free extracellular solution or SOCC antagonists (SKF96365 or NiCl(2)) decreased resting [Ca(2+)](i) in these cells. Expression of TRPC1 and TRPC6, but not TRPC4, mRNA and protein was increased in PASMCs from rats and wild-type mice exposed to CH, in PASMCs from normoxic animals cultured under hypoxic conditions (4% O(2); 60 hours), and in PASMCs in which HIF-1 was overexpressed under nonhypoxic conditions. Hypoxia-induced increases in basal [Ca(2+)](i) and TRPC expression were absent in mice partially deficient for HIF-1. These results suggest that increased TRPC expression, leading to enhanced CCE through SOCCs, may contribute to hypoxic pulmonary hypertension by facilitating Ca(2+) influx and increasing basal [Ca(2+)](i) in PASMCs and that this response is mediated by HIF-1.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16709899     DOI: 10.1161/01.RES.0000227551.68124.98

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  155 in total

1.  Peroxisome proliferator-activated receptor γ inhibits pulmonary hypertension targeting store-operated calcium entry.

Authors:  Yingfeng Wang; Wenju Lu; Kai Yang; Yan Wang; Jie Zhang; Jing Jia; Xin Yun; Lichun Tian; Yuqin Chen; Qian Jiang; Bo Zhang; Xiuqing Chen; Jian Wang
Journal:  J Mol Med (Berl)       Date:  2014-11-14       Impact factor: 4.599

2.  Targeting energetic metabolism: a new frontier in the pathogenesis and treatment of pulmonary hypertension.

Authors:  Rubin M Tuder; Laura A Davis; Brian B Graham
Journal:  Am J Respir Crit Care Med       Date:  2011-11-10       Impact factor: 21.405

Review 3.  Complex role of the HIF system in cardiovascular biology.

Authors:  Gabor Czibik
Journal:  J Mol Med (Berl)       Date:  2010-06-24       Impact factor: 4.599

Review 4.  HIF and pulmonary vascular responses to hypoxia.

Authors:  Larissa A Shimoda; Steven S Laurie
Journal:  J Appl Physiol (1985)       Date:  2013-12-12

Review 5.  TRPC6 in glomerular health and disease: what we know and what we believe.

Authors:  Johannes S Schlöndorff; Martin R Pollak
Journal:  Semin Cell Dev Biol       Date:  2006-11-20       Impact factor: 7.727

6.  Hypoxic remodelling of Ca(2+) signalling in proliferating human arterial smooth muscle.

Authors:  Parvinder K Aley; Jenny A Wilkinson; Claudia C Bauer; John P Boyle; Karen E Porter; Chris Peers
Journal:  Mol Cell Biochem       Date:  2008-07-18       Impact factor: 3.396

7.  Dysregulation of miR-135a-5p promotes the development of rat pulmonary arterial hypertension in vivo and in vitro.

Authors:  Hong-Mei Liu; Yi Jia; Ying-Xian Zhang; Jun Yan; Ning Liao; Xiao-Hui Li; Yuan Tang
Journal:  Acta Pharmacol Sin       Date:  2018-07-23       Impact factor: 6.150

8.  Divergent changes of p53 in pulmonary arterial endothelial and smooth muscle cells involved in the development of pulmonary hypertension.

Authors:  Ziyi Wang; Kai Yang; Qiuyu Zheng; Chenting Zhang; Haiyang Tang; Aleksandra Babicheva; Qian Jiang; Meichan Li; Yuqin Chen; Shane G Carr; Kang Wu; Qian Zhang; Angela Balistrieri; Christina Wang; Shanshan Song; Ramon J Ayon; Ankit A Desai; Stephen M Black; Joe G N Garcia; Ayako Makino; Jason X-J Yuan; Wenju Lu; Jian Wang
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-10-25       Impact factor: 5.464

9.  Sodium tanshinone IIA sulfonate inhibits hypoxia-induced enhancement of SOCE in pulmonary arterial smooth muscle cells via the PKG-PPAR-γ signaling axis.

Authors:  Qian Jiang; Wenju Lu; Kai Yang; Cyrus Hadadi; Xin Fu; Yuqin Chen; Xin Yun; Jie Zhang; Meichan Li; Lei Xu; Haiyang Tang; Jason X-J Yuan; Jian Wang; Dejun Sun
Journal:  Am J Physiol Cell Physiol       Date:  2016-05-18       Impact factor: 4.249

10.  Sodium tanshinone IIA sulfonate inhibits canonical transient receptor potential expression in pulmonary arterial smooth muscle from pulmonary hypertensive rats.

Authors:  Jian Wang; Qian Jiang; Limei Wan; Kai Yang; Yi Zhang; Yuqin Chen; Elizabeth Wang; Ning Lai; Lei Zhao; Hua Jiang; Yueqian Sun; Nanshan Zhong; Pixin Ran; Wenju Lu
Journal:  Am J Respir Cell Mol Biol       Date:  2012-10-11       Impact factor: 6.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.